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Cholesterol is transported both in unilamellar phosphatidylcholine vesicles and in bile salts-mixed mtcelles in native bile. The vesicular carrier of 
biliary lipids apparently has a well defined protein profile with a potent cholesterol crystallization-promoting activity. This study was conducted 
to identify and further characterize these vesicular proteins and to test the effect of isolated vesicular proteins on the cholesterol crystal formation 
in supersaturated model bile. The results confirmed that proteins are a constant component of highly purified biliary vesicles both in hepatic and 
gallbladder bile. Immunoglobuhns (IgA, IgG and IgM) and albumin are associated to the purified hepatic biliary vesicles. Furthermore, four 
different hydrophobic glycoproteins with a molecular mass of 130, 114,86, and 62-67 kDa were isolated. These glycoproteins howed no reactivity 
with anti-human whole serum or anti-immunoglobulin antibodies, suggesting that these proteins are biliary-specific. Isolated 130, 114 and 62-67 
kDa vesicular glycoprotems ignificantly decreased the cholesterol nucleation time in artificial model bile. We concluded that some, but not all, 
vesicular-bound hydrophobic glycoproteins have cholesterol pronucleating activity and they may be involved in the pathogenesis of cholesterol 
gallstone disease. 
Biliary vesicle; Cholesterol crystallization; Giycoprotein 
1. INTRODUCTION 
Phospholipid vesicles are considered to be the pri- 
mary carrier of cholesterol in bile [14]. In hepatic bile 
these vesicles are very stable, however, in concentrated 
gallbladder bile they exhibit a strong tendency to aggre- 
gation [5,6], thus leading to cholesterol crystal forma- 
tion. Biliary vesicles are commonly found associated to 
cholesterol crystals in gallbladder bile specimens of pa- 
tients with cholesterol gallstones [7]. Biliary cholesterol 
crystallization is a critical step in the pathogenesis of 
cholesterol gallstone disease [8]. 
In contrast to model bile systems [6], in native litho- 
genie gallbladder bile no correlation has been found 
between the lipid composition of the vesicular carrier 
and the cholesterol nucleation time [7,91. Factors influ- 
encing the metastability of this carrier in lithogenic bile 
are not well defined. A number of biliary proteins that 
promote, or inhibit cholesterol crystal formation have 
been isolated [lo-141. In recent studies, we have isolated 
highly purified cholesterol biliary vesicles from native 
bile of cholesterol gallstone patients [I 51. The purified 
vesicular fraction obtained with this method contained 
a unique and well-defined protein profile of six polypep- 
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tides from 52 to 200 kDa. Lipid solutions containing 
these vesicular proteins showed a potent cholesterol 
pronucleating activity in supersaturated model bile [15]. 
In the present study we isolated and partially charac- 
terized the vesicular-bound proteins and tested their 
effect on the cholesterol nucleation time of model bile. 
2. MATERIALS AND METHODS 
2.1. Isolation and purjfication of biliary vesicles 
Hepatic bile samples were obtained from 13 patients with indwelling 
T-tubes, 5 to 7 days after cholecystectomy and choledochotomy for 
cholesterol gallstone disease. Bile was collected early in the morning 
and it was immediately processed as previously described [15]. In 4 
patients we also studied gallbladder bile obtained at the moment of 
the surgical procedure. Biliary vesicles were isolated from native bile 
specimens by rapid density gradient ultracentrifugation and purified 
by sequential gel filtration chromatography [15]. 
2.2. Gel electrophoresis and irnmunoblottmg 
Proteins from purified biliary vesicles were precipitated with 8% 
(w/v) trichloroacetic acid and delipidated with ethanol/diethylether 
(1:3, v/v). Then, SDS-PAGE was performed under reducing and non- 
reducing conditions according to Laemmli [16]. Proteins were visual- 
ized by Coomassie brilliant blue staining. For immunoblotting, after 
SDS-PAGE proteins were electroblotted onto nitrocellulose [17], incu- 
bated with rabbit polyclonal anti-human whole serum, anti-albumin, 
anti-IgAa, -1gGy or -1gMp chain antibodies (Sigma Chemicals Co., 
St. Louis, MO, USA) and stained with protein A-alkaline phosphatase 
conjugate. 
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2.3. Con~a~valin A af$nity chromatography and Trzton X-f14 phase 
separation of vesicular protems 
The presence of N- or O-linked glycoside residues to vesicular pro- 
teins were determined by concanavalin A-affinity chromatography 
[IO]. To evaluate then relative hydrophob~~ydrophilic behavtour the 
vesicular proteins were analyzed by phase separation in Triton X-l 14 
U81. 
2.4. EEectroelution and renaturation of vesicular proteins from SDS- 
~o~yarr~~amide gels 
To isolate a sufficient quantity of the individual vesicular proteins 
for the cholesterol nucleation time assays, we electroeluted each pro- 
tein from preparative non-reducing SDS-PAGE. To allow recovery of 
vesicular proteins in apparent native conditions for cholesterol nucle- 
atton experiments we applied the renaturation method of Hager et al. 
[19]. Re-electrophoresis and Coomassie blue staining of each isolated 
protein fraction demonstrated a single polypeptide band with the same 
original molecular weight of every isolated protein. 
2.5. Cholesterol nucleafion time assa,vs 
The effect of the individual purified vesicular proteins electroeluted 
and renaturated from SDS-PAGE on the cholesterol crystal nuclea- 
tion time of supersaturated model bile was determined by the method 
of Groen et al. [lo]. Nucleation time represents the interval (in days) 
between zero time and the first detection of cholesterol crystals under 
polarizing microscopy. Electroeluted and renaturated vesicular pro- 
teins were resuspended in model bile buffer and were added to artifi- 
eta1 bile to achieve a final protein concentration of 20 &ml. Equal 
volumes of control solutions obtained from el~troeIution of gel pieces 
without proteins were added to model bile as control mixtures. The 
nucleation time of these control mixtures did not differ from that of 
the original model bile. 
2.6. Chemical analysis 
Cholesterol, phospholipids, bile salts and protein concentratrons in
hepatic and gallbladder bile and in vesicular fractions were determmed 
by standard techniques as previously described [20,21]. The cholest- 
erol saturation index was determined using Carey’s critical tables [22]. 
Relative composition of vesicular proteins were assessed with a den- 
sitometer unit (Shimadzu, Tokyo, Japan) after SDS-PAGE and 
Coomassie blue staining. 
3. RESULTS 
Lipid composition of hepatic and gallbladder bile 
from study patients are given in Table I. The major 
constituents by weight of the isolated and purified bil- 
iary vesicles are phospholipids (63.5 + 4.6%, mean + 1 
SD., n = 13) and cholesterol (35.5 + 5.48, p1 = 13); less 
than 1% of total lipids corresponds to bile salts. A low 
(1 + 0.2%, n = 13) but constant amount of protein is 
associated with the vesicular material. 
eon-reducing 10% SDS-PAGE of purified native bil- 
iary vesicles isolated from hepatic bile shows the pres- 
ence of a constant protein profile composed of six pol- 
ypeptides with molecular masses of 200, 130, 114, 86, 
62-67 and 52 kDa (Fig. 1, lane b). Under reducing 
conditions the 200 kDa protein is resolved into a num- 
ber of low molecular weight polypeptides in the range 
between 25-80 kDa (Fig. 1, lane 3b). AIso, the 52 kDa 
protein changed its migration to 66 kDa apparent mol. 
wt. in reducing SDS-PAGE. The 130, 114,86 and 62-67 
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Table I 
Composition and cholesterol nucleation time of hepatrc and gallblad- 
der bile from patients with gallstone disease 
Hepatic Gallbladder 
bile bile 
Biliary lipid concentration (mM) 
Btle actds 22f 13 83? 12 
Phospholipids 6.4 * 3.1 17.3 + 7.8 
Cholesterol 5.7 f 2.8 7.4 _+ 2.2 
Protein concentration (g/l) 1.8 I? 0.7 5.4 I? 1.9 
Cholesterol saturation (%) Ill * 55 137 + 28 
Vesicular cholesterol (%) 68 + 8 26 + 6 
Cholesterol nucleation ttme (days) 1524 3+1 
Values represent he mean f 1 SD. of bile samples from 13 different 
patients. 
kDa mol.wt. proteins did not show variations of elec- 
trophoretic migration under reducing conditions (Fig. 
1, lane lb vs. 3b). 
In some patients, we were also able to obtain gall- 
bladder bile that contained a low but significant vesicu- 
lar cholesterol fraction (range 18-33%. n = 4). Vesicles 
were isolated and purified as described above for he- 
patic bile samples. As shown in Fig. 1, lane 2 a similar 
protein profile as in hepatic biliary vesicles was found 
under non-reducing SDS-PAGE. 
Immunoblotting of vesicular proteins separated on 
SDS-PAGE under non-reducing conditions were first 
carried out with rabbit anti-human whole serum anti- 
body. Only two major bands corresponding to the 200 
and 52 kDa proteins became visible (result not shown). 
Under reducing conditions (Fig. Z), anti-albumin anti- 
body recognized only the 66 kDa band (lane 3) con- 
firming that this protein corresponded to biliary albu- 
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Fig. 1. SDS-PAGE of vesicular proteins stained wrth Coomassie blue. 
100 pg of total protein were applied to each lane. (1) Lane a, protein 
molecular weight markers; lane b, hepatic bihary vesicles under non- 
reducing condttions. (2) Vesicles harvested from gallbladder bile under 
reducing conditions. (3) Lane a, molecular weight markers; lane b, 
hepatic bthary vesicles under reducing conditions. 
The relative d~st~b~t~o~ of ves~c~~~r proteins from 
heretic bile was assessed by s~~~~~g of ~oomassje 
brilliant blue stained SDS-PAGE with a deusitometet 
unit. The 200 and 86 kDa proteins were found in minar 
amoxmts in most samples and were absent in some c$ 
them, AI~urn~~ (the 52 kDa bard in ~o~-red~c~~g SDS- 
PACE) was the pr~d~mi~a~t protein amounting for 
35.6 4 5.7% (mean k S.D., R = 7) of th.he totd v~si~~a~ 
protein content. Interestingly, the 130, 114, and 62-63 
kDa proteins represent on average 10.7 I 5.3, 
142 J: 7-5 and 26.2 It 17,l Z and together they were the 
mast pr~daminant in four sampfes, 
‘i 2 3 4 5 fi 
Fig. 3. SDS-PAGE. of vesicular proteins after ~~n~~~a~~*-A ~~~i~y 
chromato~~h~. Lane 1, unbmmd fractiCx%; Iane 2, washout. of the 
S&imo with b&er; lam? 3, eh%ate of the bottnd fr~t~o~ using b&e 
containing iz-~methyhnznnopyranos~de; lane 4 and 5, ~a~~~~ ofthe 
coIumn with glycoside buffer; lane 6, original vesicular protein sample. 
The dark band shown at the bottom ofthe lanes corresponds to Con-A 
released from the column. 
that, as expected, the 52 kDa protein ~~~b~rn~~~ was 
completely recovered in the unbound fractions. More- 
over, part of the 200 kDa and also some of the other 
proteins were recovered in this fraction too. The 130, 
i t43 86 alrd 62-57 kDr~ were foxed in the Con A hate 
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130 200 ldh MIXTURE 
YESICULAR PROTEINS ( SS~,ml, per assay) 
Fig. 5. Effect of isolated vesicular proteins on the cholesterol crystal 
nucleation time of supersaturated artificial model bile. Each column 
represents the mean 2 1 S.D. of 5 to 6 different assays. In a series of 
experiments a mixture of 3.5 &/ml of each protein was added to the 
assay. The asterisks indicate a significant difference at the P < 0.05 
from the control (Student’s t-test). 
together with the 200 kDa protein (Fig. 3, lane 3). These 
results suggest hat most of the vesicular proteins are 
glycoproteins. 
Vesicular-bound proteins were analyzed by phase 
separation in Triton X-l 14 solution. As shown in Fig. 
4, lane 2, the 130, 114, 86, 62-67 and a small fraction 
of the 200 kDa glycoproteins had a strong hydrophobic 
behaviour with depletion from the aqueous phase and 
complete recovery in the detergent phase. In contrast, 
the 52 kDa and the major part of the 200 kDa mol.wt. 
protein were recovered in the aqueous phase. These 
findings indicate that most of the vesicular-bound pro- 
teins possess hydrophobic domains with the ability to 
bind detergents, suggesting that these glycoproteins 
could be bound by hydrophobic interaction to the core 
of the lipid bilayer of the biliary vesicles. 
To assess the cholesterol nucleation influencing activ- 
ity of the vesicular proteins, supersaturated model bile 
was mixed with aliquots containing isolated and renatu- 
rated vesicular proteins. The nucleation time of these 
mixtures was compared with control mixtures prepared 
as described. As shown in Fig. 5, the 130, 114, and 
62-67 kDa glycoproteins ignificantly decreased the nu- 
cleation time of model bile by 50% at a concentration 
of 20 ,ug/ml. At this concentration. the 200, 86 and 52 
kDa proteins lacked nucleation promoting activity (re- 
sult with the 52 kDa protein, corresponding to albumin 
by Western blotting, is not shown). Finally, mixtures of 
all vesicular proteins at the same total concentration 
(approximately 3.5 ,&ml of each one) reduced the 
cholesterol nucleation time in the same proportion. 
4. DISCUSSION 
The major finding of this study is that native purified 
biliary vesicles contain a constant protein profile, both 
from hepatic and gallbladder bile which by mass repre- 
sents approximately 1% of vesicle constituents. We 
48 
found a series of three hydrophobic glycoproteins (mo- 
lecular weights of 130, 114 and 62-67 kDa) with potent 
cholesterol crystallization-promoting activity. Isolated 
and purified 86 kDa-hydrophobic glycoprotein without 
apparent pronucleating activity and a series of immu- 
noglobulins.??? 
In recent years, several biliary proteins with cholest- 
erol pronucleating or antinucleating activity have been 
described [10-l 51. Biliary immunoglobulins, particu- 
larly IgM and IgA, have been identified as cholesterol 
nucleation promoter proteins at concentrations usually 
found in gallbladder bile [ 131. In the present study, ve- 
sicular immunoglobulins isolated from native hepatic 
bile did not exhibit pronucleating effect at 20 pg/ml 
concentration, which corresponds to one-third of the 
concentration used in the study by Harvey et al. [13]. 
Immunoglobulins isolated from the vesicular fraction 
only constituted a minor component of total vesicular 
proteins, as compared to the hydrophobic glycoproteins 
with cholesterol nucleation promoting effect (the 130, 
114, 62-67 kDa proteins) and albumin. The 130 kDa 
glycoprotein found in this study may be the 130 kDa 
pronucleating lycoprotein described by Groen et al. in 
both hepatic and gallbladder bile of patients with gall- 
stones [lo,1 11. 
With respect o the mechanism of cholesterol crystal- 
lization promoting activity, we could speculate that the 
hydrophobicity of the pronucleating glycoproteins de- 
termines their binding to the core of the lipid bilayer of 
the biliary vesicles, favouring vesicular aggregation and 
fusion, the two critical pronucleating events in the com- 
plex pathophysiological cascade of the cholesterol crys- 
tal formation in gallstone disease. It is interesting to 
note that gallbladder mucin also accelerates cholesterol 
crystal nucleation in model bile [23], probably by a mo- 
lecular mechanism dependent on the hydrophobic do- 
mains of the mucin protein core [24]. Present results are 
consistent with the current hypothesis of the pathogene- 
sis of cholesterol gallstone disease and they strongly 
suggest hat cholesterol crystal formation and growth 
may be finally determined by a series of different biliary 
factors, including the presence of proteins, originated in 
hepatic as well as in gallbladder bile. 
Presently, the nature, origin and functional signifi- 
cance of the four vesicular hydrophobic glycoproteins 
described in this study remain unknown. Because bil- 
iary vesicles probably represent he primary mechanism 
of biliary lipid secretion, they might be related to the 
process of sorting, intracellular transport and canalicu- 
lar secretion of the precursor carrier(s) of biliary lipids. 
The true functional significance of the vesicular 
glycoproteins could become apparent after their identi- 
fication, quantitation and correlation to the secretory 
process of biliary lipids. 
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